Llwytho...
Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model
BACKGROUND: Influenza B virus infections remain insufficiently studied and antiviral management in immunocompromised patients is not well defined. The treatment regimens for these high-risk patients, which have elevated risk of severe disease-associated complications, require optimization and can be...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Antimicrob Chemother |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6477984/ https://ncbi.nlm.nih.gov/pubmed/30715325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dky560 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|